ImmunityBio resubmits cancer treatment application to FDA
Go back to ImmunityBio resubmits cancer treatment application to FDA| (NASDAQ: IBRX) | Delayed: 7.93 -0.2 (2.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.13 | 52 Week High | $ | |||
| Open | $7.90 | 52 Week Low | $ | |||
| Day High | $8.00 | P/E | N/A | |||
| Day Low | $7.74 | EPS | $ | |||
| Volume | 5,833,404 | |||||
